| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -1.02 | 0.55 | -0.75 | 0.00 |
| Net Changein Cash | 0.69 | -0.16 | 0.01 | -0.18 |
| Cash Taxes Paid | 0.18 | 0.20 | 0.06 | 0.10 |
| Net Income/ Starting Line | 0.87 | 1.01 | 0.98 | -0.95 |
| Changesin Working Capital | 0.13 | -1.72 | 0.39 | -0.72 |
| Cashfrom Operating Activities | 2.64 | 0.82 | 2.48 | -0.29 |
| Cash Interest Paid | 0.53 | 0.46 | 0.42 | 0.43 |
| Cashfrom Financing Activities | -1.55 | 0.10 | -1.17 | -0.43 |
| Depreciation/ Depletion | 1.25 | 1.20 | 0.81 | 1.09 |
| Other Investing Cash Flow Items Total | 1.79 | 0.27 | 0.26 | 0.95 |
| Capital Expenditures | -2.19 | -1.35 | -1.56 | -0.42 |
| period Type | - | - | - | - |
| Non- Cash Items | 0.40 | 0.33 | 0.29 | 0.29 |
| Financing Cash Flow Items | -0.53 | -0.45 | -0.42 | -0.43 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -0.40 | -1.08 | -1.30 | 0.54 |
Beryl Drugs Dividend Beryl Drugs Bonus Beryl Drugs News Beryl Drugs AGM Beryl Drugs Rights Beryl Drugs Splits Beryl Drugs Board Meetings Beryl Drugs Key Metrics Beryl Drugs Shareholdings Beryl Drugs Profit Loss Beryl Drugs Balance Sheet Beryl Drugs Q1 Results Beryl Drugs Q2 Results Beryl Drugs Q3 Results Beryl Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks